title: No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls.
abstract: New ELISA assays were developed to measure immunoreactivity for XMRV. Antibody titers were measured in a cohort of prostate cancer cases and cancer free controls from the central United States. No statistically significant differences were observed in immunoreactivity between cases and controls for either the XMRV-env or the XMRV-gag antigen.
authors.affiliation: Stanley Division of Developmental Virology, Department of Pediatrics, Johns Hopkins University, Baltimore, MD 21287, United States. ssabunc1@jhmi.edu
authors.forename: Sarven
authors.initials: S
authors.lastname: Sabunciyan
authors.forename: Nataniel
authors.initials: N
authors.lastname: Mandelberg
authors.forename: Charles S
authors.initials: CS
authors.lastname: Rabkin
authors.forename: Robert
authors.initials: R
authors.lastname: Yolken
authors.forename: Raphael
authors.initials: R
authors.lastname: Viscidi
mesh_terms: D000914:Antibodies, Viral / Q000276:immunology*; D015331:Cohort Studies; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D015686:Gene Products, env / Q000276:immunology; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000276:immunology* / Q000821:virology; D015203:Reproducibility of Results; D012192:Retroviridae Infections / Q000175:diagnosis / Q000276:immunology* / Q000821:virology; D012680:Sensitivity and Specificity; D058008:Xenotropic murine leukemia virus-related virus / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D015686:Gene Products, env